693
Views
8
CrossRef citations to date
0
Altmetric
Review Articles

Evasion mechanisms of the type I interferons responses by influenza A virus

, , & ORCID Icon
Pages 420-432 | Received 10 Feb 2020, Accepted 04 Jun 2020, Published online: 25 Jul 2020

References

  • Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413(6857):732–738.
  • Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP-Y. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 30(4):556–565.
  • Bauer DLV, Tellier M, Martínez-Alonso M, Nojima T, Proudfoot NJ, Murphy S, Fodor E. 2018. Influenza virus mounts a two-pronged attack on host RNA polymerase II transcription. Cell Rep. 23(7):2119–2129 e3.
  • Blasius AL, Beutler B. 2010. Intracellular toll-like receptors. Immunity. 32(3):305–315.
  • Bowie AG, Unterholzner L. 2008. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol. 8(12):911–922.
  • Chan AY, Vreede FT, Smith M, Engelhardt OG, Fodor E. 2006. Influenza virus inhibits RNA polymerase II elongation. Virology. 351(1):210–217.
  • Chen H, Yuan H, Gao R, Zhang J, Wang D, Xiong Y, Fan G, Yang F, Li X, Zhou J, et al. 2014. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet. 383(9918):714–721.,
  • Chen ZJ, Sun LJ. 2009. Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell. 33(3):275–286.
  • Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, Newman GR, Jasani B. 2001. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 247(1–2):163–174.
  • Cui S, Eisenächer K, Kirchhofer A, Brzózka K, Lammens A, Lammens K, Fujita T, Conzelmann K-K, Krug A, Hopfner K-P, et al. 2008. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell. 29(2):169–179.,
  • Dang Y, Kedersha N, Low W-K, Romo D, Gorospe M, Kaufman R, Anderson P, Liu JO. 2006. Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J Biol Chem. 281(43):32870–32878.
  • Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers GJ, Mechti N, Vicenzi E. 2013. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation. J Virol. 87(8):4523–4533.
  • Eng CL, Tong JC, Tan TW. 2014. Predicting host tropism of influenza A virus proteins using random forest. BMC Med Genomics. 7(Suppl 3):S1.
  • Engelhardt OG, Smith M, Fodor E. 2005. Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J Virol. 79(9):5812–5818.
  • Fabozzi G, Oler AJ, Liu P, Chen Y, Mindaye S, Dolan MA, Kenney H, Gucek M, Zhu J, Rabin RL, et al. 2018. Strand-specific dual RNA sequencing of bronchial epithelial cells infected with influenza A/H3N2 viruses reveals splicing of gene segment 6 and novel host-virus interactions. J Virol. 92(17). DOI:10.1128/JVI.00518-18.
  • Feng W, Sun X, Shi N, Zhang M, Guan Z, Duan M. 2017. Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response. Biochem Biophys Res Commun. 482(4):1107–1113.
  • Ferko B, Stasakova J, Romanova J, Kittel C, Sereinig S, Katinger H, Egorov A. 2004. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol. 78(23):13037–13045.
  • Fernandez MV, Miller E, Krammer F, Gopal R, Greenbaum BD, Bhardwaj N. 2016. Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells. J Leukoc Biol. 99(5):723–734.
  • Forero A, Tisoncik-Go J, Watanabe T, Zhong G, Hatta M, Tchitchek N, Selinger C, Chang J, Barker K, Morrison J, et al. 2015. The 1918 influenza virus PB2 protein enhances virulence through the disruption of inflammatory and wnt-mediated signaling in mice. J Virol. 90(5):2240–2253.
  • Fu B, Wang L, Ding H, Schwamborn JC, Li S, Dorf ME. 2015. TRIM32 senses and restricts influenza A virus by ubiquitination of PB1 polymerase. PLoS Pathog. 11(6):e1004960.
  • Gack MU, Albrecht RA, Urano T, Inn K-S, Huang I-C, Carnero E, Farzan M, Inoue S, Jung JU, García-Sastre A, et al. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 5(5):439–449.,
  • Gack MU, Shin YC, Joo C-H, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 446(7138):916–920.,
  • Gannage M, et al. 2009. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe. 6(4):367–380.,
  • Gao S, Song L, Li J, Zhang Z, Peng H, Jiang W, Wang Q, Kang T, Chen S, Huang W, et al. 2012. Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell Microbiol. 14(12):1849–1866.,
  • Gao S, Wu J, Liu R-Y, Li J, Song L, Teng Y, Sheng C, Liu D, Yao C, Chen H, et al. 2015. Interaction of NS2 with AIMP2 facilitates the switch from ubiquitination to SUMOylation of M1 in influenza A virus-infected cells. J Virol. 89(1):300–311.,
  • Garcia-Sastre A. 2011. Induction and evasion of type I interferon responses by influenza viruses. Virus Res. 162(1–2):12–18.
  • Gaucherand L, Porter BK, Levene RE, Price EL, Schmaling SK, Rycroft CH, Kevorkian Y, McCormick C, Khaperskyy DA, Gaglia MM, et al. 2019. The Influenza A virus endoribonuclease PA-X usurps host mRNA processing machinery to limit host gene expression. Cell Rep. 27(3):776–792 e7.,
  • Goraya MU, Wang S, Munir M, Chen J-L. 2015. Induction of innate immunity and its perturbation by influenza viruses. Protein Cell. 6(10):712–721.
  • Graef KM, Vreede FT, Lau Y-F, McCall AW, Carr SM, Subbarao K, Fodor E. 2010. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol. 84(17):8433–8445.
  • Grimm D, Staeheli P, Hufbauer M, Koerner I, Martínez-Sobrido L, Solórzano A, García-Sastre A, Haller O, Kochs G. 2007. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci Usa. 104(16):6806–6811.
  • Hale BG, Jackson D, Chen Y-H, Lamb RA, Randall RE. 2006. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci Usa. 103(38):14194–14199.
  • Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, Hickman D, Hai R, Schmolke M, Lowen AC, Perez DR, et al. 2010. Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol. 84(14):6909–6922.,
  • Hayashi F, Means TK, Luster AD. 2003. Toll-like receptors stimulate human neutrophil function. Blood. 102(7):2660–2669.
  • Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424(6950):743–748.,
  • Shanyu Huang LL, Junping Li, Qian Wang, Qingqing Zhao, Cehnchen Zhou, Yuhui Zhao, Guangwen Wang, Qibing Li, Fandi Kong, Chengjun Li, Hualan Chen, Li Jiang. 2019. Study on interaction between influenza virus NS1 protein and host DOK6 protein. Chin J Prev Vet Med. 41(10):6.
  • Huangfu W-C, Qian J, Liu C, Liu J, Lokshin AE, Baker DP, Rui H, Fuchs SY. 2012. Inflammatory signaling compromises cell responses to interferon alpha. Oncogene. 31(2):161–172.
  • Ingle H, Kumar S, Raut AA, Mishra A, Kulkarni DD, Kameyama T, Takaoka A, Akira S, Kumar H. 2015. The microRNA miR-485 targets host and influenza virus transcripts to regulate antiviral immunity and restrict viral replication. Sci Signal. 8(406):ra126.
  • Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, Takada A, Kida H, Miyazaki T. 2010. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem. 285(42):32064–32074.
  • Jagger BW, Wise HM, Kash JC, Walters K-A, Wills NM, Xiao Y-L, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, et al. 2012. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science. 337(6091):199–204.,
  • Jahan AS, Biquand E, Muñoz-Moreno R, Le Quang A, Mok CK-P, Wong HH, Teo QW, Valkenburg SA, Chin AWH, Man Poon LL, et al. 2020. OTUB1 is a key regulator of RIG-I-dependent immune signaling and is targeted for proteasomal degradation by influenza A NS1. Cell Rep. 30(5):1570.e6–1584.e6.
  • Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS, Bakaletz LO, Durbin RK, Flaño E, Durbin JE. 2007. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol. 81(18):9790–9800.
  • Jureka AS, Kleinpeter AB, Tipper JL, Harrod KS, Petit CM. 2020. The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I. J Biol Chem. 295(4):1153–1164.
  • Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441(7089):101–105.,
  • Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat Immunol. 7(2):131–137.
  • Khaperskyy DA, Emara MM, Johnston BP, Anderson P, Hatchette TF, McCormick C. 2014. Influenza a virus host shutoff disables antiviral stress-induced translation arrest. PLoS Pathog. 10(7):e1004217.
  • Khaperskyy DA, Hatchette TF, McCormick C. 2012. Influenza A virus inhibits cytoplasmic stress granule formation. Faseb J. 26(4):1629–1639.
  • Khaperskyy DA, Schmaling S, Larkins-Ford J, McCormick C, Gaglia MM. 2016. Selective degradation of Host RNA polymerase II transcripts by influenza A virus PA-X host shutoff protein. PLoS Pathog. 12(2):e1005427.
  • Khongnomnan K, Makkoch J, Poomipak W, Poovorawan Y, Payungporn S. 2015. Human miR-3145 inhibits influenza A viruses replication by targeting and silencing viral PB1 gene. Exp Biol Med (Maywood)). 240(12):1630–1639.
  • Kilbourne ED. 2006. Influenza pandemics of the 20th century. Emerging Infect Dis. 12(1):9–14.
  • Kim SS-Y, Sze L, Liu C, Lam K-P. 2019. The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance interferon-β response. J Biol Chem. 294(16):6430–6438.
  • Kochs G, Garcia-Sastre A, Martinez-Sobrido L. 2007. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol. 81(13):7011–7021.
  • Krug RM. 2015. Functions of the influenza A virus NS1 protein in antiviral defense. Curr Opin Virol. 12:1–6.
  • Levene RE, Gaglia MM. 2018. Host shutoff in influenza A virus: many means to an end. Viruses. 10(9):475.
  • Li S, Min J-Y, Krug RM, Sen GC. 2006. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology. 349(1):13–21.
  • Li W, Chen H, Sutton T, Obadan A, Perez DR. 2014. Interactions between the influenza A virus RNA polymerase components and retinoic acid-inducible gene I. J Virol. 88(18):10432–10447.
  • Liu C-H, Zhou L, Chen G, Krug RM. 2015. Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein. Proc Natl Acad Sci USA. 112(45):14048–14053.
  • Liu J, HuangFu W-C, Kumar KGS, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs SY, et al. 2009. Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe. 5(1):72–83.
  • Liu X, Zhao Z, Xu C, Sun L, Chen J, Zhang L, Liu W. 2012. Cyclophilin A restricts influenza A virus replication through degradation of the M1 protein. PLoS One. 7(2):e31063
  • Loveday E-K, Diederich S, Pasick J, Jean F. 2015. Human microRNA-24 modulates highly pathogenic avian-origin H5N1 influenza A virus infection in A549 cells by targeting secretory pathway furin. J Gen Virol. 96(Pt 1):30–39.
  • Lu C, Xing Y, Cai H, Shi Y, Liu J, Huang Y. 2019. Identification and analysis of long non-coding RNAs in response to H5N1 influenza viruses in duck (Anas platyrhynchos). BMC Genomics. 20(1):36
  • Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, García-Sastre A, Heins G, Wolff T, et al. 2002. The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol. 76(21):11166–11171.,
  • Maemura T, Fukuyama S, Sugita Y, Lopes TJS, Nakao T, Noda T, Kawaoka Y. 2018. Lung-derived exosomal miR-483-3p regulates the innate immune response to influenza virus infection. J Infect Dis. 217(9):1372–1382.
  • McAuley JL, Tate MD, MacKenzie-Kludas CJ, Pinar A, Zeng W, Stutz A, Latz E, Brown LE, Mansell A. 2013. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog. 9(5):e1003392
  • Meckes DG, Jr., Raab-Traub N. 2011. Microvesicles and viral infection. J Virol. 85(24):12844–12854.
  • Mok BW-Y, Song W, Wang P, Tai H, Chen Y, Zheng M, Wen X, Lau S-Y, Wu WL, Matsumoto K, et al. 2012. The NS1 protein of influenza A virus interacts with cellular processing bodies and stress granules through RNA-associated protein 55 (RAP55) during virus infection. J Virol. 86(23):12695–12707.,
  • Moriyama M, Koshiba T, Ichinohe T. 2019. Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses. Nat Commun. 10(1):4624
  • Munoz-Moreno R, et al. 2019. Viral fitness landscapes in diverse host species reveal multiple evolutionary lines for the NS1 gene of influenza A viruses. Cell Rep. 29(12):3997.e5–4009 e5.
  • Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell. 1(7):991–1000.
  • Nogales A, Martinez-Sobrido L, Topham D, DeDiego M. 2018. Modulation of innate immune responses by the influenza A NS1 and PA-X proteins. Viruses. 10(12):708.
  • Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. 2010. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe. 8(6):496–509.
  • Othumpangat S, Noti JD, Blachere FM, Beezhold DH. 2013. Expression of non-structural-1A binding protein in lung epithelial cells is modulated by miRNA-548an on exposure to influenza A virus. Virology. 447(1–2):84–94.
  • Pang IK, Iwasaki A. 2011. Inflammasomes as mediators of immunity against influenza virus. Trends Immunol. 32(1):34–41.
  • Park E‐S, Byun YH, Park S, Jang YH, Han W‐R, Won J, Cho KC, Kim DH, Lee AR, Shin G‐C, et al. 2019. Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenza. Embo J. 38(10). DOI:10.15252/embj.201899475.
  • Parrish CR, Murcia PR, Holmes EC. 2015. Influenza virus reservoirs and intermediate hosts: dogs, horses, and new possibilities for influenza virus exposure of humans. J Virol. 89(6):2990–2994.
  • Patel D, Schultz LW, Umland TC. 2013. Influenza A polymerase subunit PB2 possesses overlapping binding sites for polymerase subunit PB1 and human MAVS proteins. Virus Res. 172(1–2):75–80.
  • Pauli E-K, Schmolke M, Wolff T, Viemann D, Roth J, Bode JG, Ludwig S. 2008. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog. 4(11):e1000196.
  • Peiris JS, de Jong MD, Guan Y. 2007. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev. 20(2):243–267.
  • Perry AK, Chow EK, Goodnough JB, Yeh W-C, Cheng G. 2004. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med. 199(12):1651–1658.
  • Pinar A, Dowling JK, Bitto NJ, Robertson AAB, Latz E, Stewart CR, Drummond GR, Cooper MA, McAuley JL, Tate MD, et al. 2017. PB1-F2 peptide derived from avian influenza A Virus H7N9 induces inflammation via activation of the NLRP3 inflammasome. J Biol Chem. 292(3):826–836.
  • Pizzorno A, Dubois J, Machado D, Cartet G, Traversier A, Julien T, Lina B, Bourdon J-C, Rosa-Calatrava M, Terrier O, et al. 2018. Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection. Sci Rep. 8(1):3746.
  • Poovorawan Y, Pyungporn S, Prachayangprecha S, Makkoch J. 2013. Global alert to avian influenza virus infection: from H5N1 to H7N9. Pathog Glob Health. 107(5):217–223.
  • Pothlichet J, Chignard M, Si-Tahar M. 2008. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol. 180(4):2034–2038.
  • Pu J, Wang S, Yin Y, Zhang G, Carter RA, Wang J, Xu G, Sun H, Wang M, Wen C, et al. 2015. Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proc Natl Acad Sci USA. 112(2):548–553.,
  • Quan F-S, Kim M-C, Lee B-J, Song J-M, Compans RW, Kang S-M. 2012. Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection. Virology. 430(2):127–135.
  • Raab-Traub N, Dittmer DP. 2017. Viral effects on the content and function of extracellular vesicles. Nat Rev Microbiol. 15(9):559–572.
  • Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villán E, García-Sastre A, Gack MU. 2012. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog. 8(11):e1003059.
  • Raposo G, Stoorvogel W. 2013. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 200(4):373–383.
  • Ren R, Wu S, Cai J, Yang Y, Ren X, Feng Y, Chen L, Qin B, Xu C, Yang H, et al. 2017. The H7N9 influenza A virus infection results in lethal inflammation in the mammalian host via the NLRP3-caspase-1 inflammasome. Sci Rep. 7(1):7625,
  • Rigby RE, Wise HM, Smith N, Digard P, Rehwinkel J. 2019. PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infection. Sci Rep. 9(1):7216
  • Rivas HG, Schmaling SK, Gaglia MM. 2016. Shutoff of host gene expression in influenza A virus and herpesviruses: similar mechanisms and common themes. Viruses. 8(4):102
  • Rodriguez A, Perez-Gonzalez A, Nieto A. 2007. Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J Virol. 81(10):5315–5324.
  • Samir M, Vidal RO, Abdallah F, Capece V, Seehusen F, Geffers R, Hussein A, Ali AAH, Bonn S, Pessler F, et al. 2020. Organ-specific small non-coding RNA responses in domestic (Sudani) ducks experimentally infected with highly pathogenic avian influenza virus (H5N1). RNA Biol. 17(1):112–124.,
  • Satterly N, Tsai P-L, van Deursen J, Nussenzveig DR, Wang Y, Faria PA, Levay A, Levy DE, Fontoura BMA. 2007. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci Usa. 104(6):1853–1858.
  • Schindler C, Levy DE, Decker T. 2007. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 282(28):20059–20063.
  • Schulz KS, Mossman KL. 2016. Viral evasion strategies in type I IFN signaling - a summary of recent developments. Front Immunol. 7:498.
  • Sharma K, Tripathi S, Ranjan P, Kumar P, Garten R, Deyde V, Katz JM, Cox NJ, Lal RB, Sambhara S, et al. 2011. Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation. PLoS One. 6(6):e20215,
  • Slaine P, Kleer M, Smith N, Khaperskyy D, McCormick C. 2017. Stress granule-inducing eukaryotic translation initiation factor 4A inhibitors block influenza A virus replication. Viruses. 9(12):388.
  • Song L, Liu H, Gao S, Jiang W, Huang W. 2010. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol. 84(17):8849–8860.
  • Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, Perez DR, García-Sastre A, Palese P. 2009. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol. 83(4):1742–1753.
  • Su W-C, Chen Y-C, Tseng C-H, Hsu PW-C, Tung K-F, Jeng K-S, Lai MMC. 2013. Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci Usa. 110(43):17516–17521.
  • Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, Narita R, Gale M, Inagaki F, Fujita T. 2008. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell. 29(4):428–440.
  • Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol Rev. 227(1):75–86.
  • Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, García-Sastre A. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol. 74(17):7989–7996.
  • Te Velthuis AJ, Fodor E. 2016. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol. 14(8):479–493.
  • Thulasi Raman SN, Liu G, Pyo HM, Cui YC, Xu F, Ayalew LE, Tikoo SK, Zhou Y. 2016. DDX3 interacts with influenza A virus NS1 and NP proteins and exerts antiviral function through regulation of stress granule formation. J Virol. 90(7):3661–3675.
  • Tong S, Li Y, Rivailler P, Conrardy C, Castillo DAA, Chen L-M, Recuenco S, Ellison JA, Davis CT, York IA, et al. 2012. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci USA. 109(11):4269–4274.,
  • Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, Yang H, Chen X, Recuenco S, Gomez J, et al. 2013. New world bats harbor diverse influenza A viruses. PLoS Pathog. 9(10):e1003657.
  • Varga ZT, Ramos I, Hai R, Schmolke M, García-Sastre A, Fernandez-Sesma A, Palese P. 2011. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 7(6):e1002067
  • Vreede FT, Chan AY, Sharps J, Fodor E. 2010. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells. Virology. 396(1):125–134.
  • Wang R, Zhu Y, Lin X, Ren C, Zhao J, Wang F, Gao X, Xiao R, Zhao L, Chen H, et al. 2019. Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production. Autophagy. 15(7):1163–1181.,
  • Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen J-L. 2014. Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression. J Virol. 88(15):8375–8385.
  • Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, García-Sastre A. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol. 74(24):11566–11573.
  • Weber M, Sediri H, Felgenhauer U, Binzen I, Bänfer S, Jacob R, Brunotte L, García-Sastre A, Schmid-Burgk JL, Schmidt T, et al. 2015. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe. 17(3):309–319.
  • Wei F, Jiang Z, Sun H, Pu J, Sun Y, Wang M, Tong Q, Bi Y, Ma X, Gao GF, et al. 2019. Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling. PLoS Pathog. 15(10):e1008062.
  • Xia C, Vijayan M, Pritzl CJ, Fuchs SY, McDermott AB, Hahm B. 2015. Hemagglutinin of influenza A virus antagonizes type I Interferon (IFN) responses by inducing degradation of type I IFN receptor 1. J Virol. 90(5):2403–2417.
  • Xia C, Wolf JJ, Sun C, Xu M, Studstill CJ, Chen J, Ngo H, Zhu H, Hahm B. 2020. PARP1 enhances influenza A virus propagation by facilitating degradation of host type I interferon receptor. J Virol. 94(7). DOI:10.1128/JVI.01572-19.
  • Xia C, Wolf JJ, Vijayan M, Studstill CJ, Ma W, Hahm B. 2018. Casein kinase 1α mediates the degradation of receptors for type I and type II interferons caused by hemagglutinin of influenza A virus. J Virol. 92(7). DOI:10.1128/JVI.00006-18.
  • Yi C, Zhao Z, Wang S, Sun X, Zhang D, Sun X, Zhang A, Jin M. 2017. Influenza A virus PA antagonizes interferon-β by interacting with interferon regulatory factor 3. Front Immunol. 8:1051
  • Yoshizumi T, Ichinohe T, Sasaki O, Otera H, Kawabata S-i, Mihara K, Koshiba T. 2014. Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. Nat Commun. 5:4713.
  • Zamarin D, Ortigoza MB, Palese P. 2006. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol. 80(16):7976–7983.
  • Zhang J, Li G, Liu X, Wang Z, Liu W, Ye X. 2009. Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA. J Gen Virol. 90(Pt 11):2751–2758.
  • Zheng B, Zhou J, Wang H. 2020. Host microRNAs and exosomes that modulate influenza virus infection. Virus Res. 279:197885.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.